BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahn J, Flamm SL. Hepatocellular carcinoma. Dis Mon 2004;50:556-73. [PMID: 15616490 DOI: 10.1016/j.disamonth.2004.10.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Kim CJ, Shin JW, Jung SW, Park BR, Park NH. Somatic Mutation of ARHI Gene in Hepatocellular Carcinomas. Pathol Oncol Res 2015;21:1277-9. [PMID: 26143066 DOI: 10.1007/s12253-015-9924-9] [Reference Citation Analysis]
2 Khatri G, Merrick L, Miller FH. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am. 2010;18:421-450, x. [PMID: 21094448 DOI: 10.1016/j.mric.2010.08.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
3 Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14:4300-4308. [PMID: 18666317 DOI: 10.3748/wjg.v14.i27.4300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Jung KH, Noh JH, Kim JK, Eun JW, Bae HJ, Chang YG, Kim MG, Park WS, Lee JY, Lee SY, Chu IS, Nam SW. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer. Hepatology. 2012;56:644-657. [PMID: 22392728 DOI: 10.1002/hep.25699] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
5 Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW, Kanzler S. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol. 2006;45:419-428. [PMID: 16842882 DOI: 10.1016/j.jhep.2006.04.010] [Cited by in Crossref: 160] [Cited by in F6Publishing: 159] [Article Influence: 10.0] [Reference Citation Analysis]
6 Vishnevsky VA, Ayvazyan KA, Ikramov RZ, Ionkin DA, Zhavoronkova OI, Stepanova YA, Varava AB, Kovalenko YA, Zharikov YO, Goncharov AB, Olifir AA, Pakhomova AY, Bugaev SA, Zhao AV. Modern principles of hepatocellular carcinoma treatment. Ann hir gepatol 2020;25:15-26. [DOI: 10.16931/1995-5464.2020215-26] [Reference Citation Analysis]
7 Chang P, Chi C, Chau G, Li F, Tsai Y, Wu J, Wu Lee Y. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 2006;25:1991-2003. [DOI: 10.1038/sj.onc.1209239] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 5.6] [Reference Citation Analysis]
8 Waly Raphael S, Yangde Z, Yuxiang C. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol 2012;2012:421673. [PMID: 22655206 DOI: 10.5402/2012/421673] [Cited by in Crossref: 25] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
9 Chitapanarux T, Phornphutkul K. Risk Factors for the Development of Hepatocellular Carcinoma in Thailand. J Clin Transl Hepatol 2015;3:182-8. [PMID: 26623264 DOI: 10.14218/JCTH.2015.00025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 0.4] [Reference Citation Analysis]
10 Chen H, Takahashi S, Imamura M, Okutani E, Zhang Z, Chayama K, Chen B. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo: . Chinese Medical Journal 2007;120:898-904. [DOI: 10.1097/00029330-200705020-00009] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
11 Li CX, Yu B, Shi L, Geng W, Lin QB, Ling CC, Yang M, Ng KT, Huang JD, Man K. 'Obligate' anaerobic Salmonella strain YB1 suppresses liver tumor growth and metastasis in nude mice. Oncol Lett 2017;13:177-83. [PMID: 28123538 DOI: 10.3892/ol.2016.5453] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
12 Parikh A, Taouli B. Imaging of hepatocellular carcinoma: current concepts. Recent Results Cancer Res. 2013;190:33-55. [PMID: 22941012 DOI: 10.1007/978-3-642-16037-0_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
13 Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14(27): 4300-4308 [PMID: 18666317 DOI: 10.3748/wjg.14.4300] [Cited by in CrossRef: 408] [Cited by in F6Publishing: 377] [Article Influence: 29.1] [Reference Citation Analysis]
14 Hanczko R, Fernandez DR, Doherty E, Qian Y, Vas G, Niland B, Telarico T, Garba A, Banerjee S, Middleton FA, Barrett D, Barcza M, Banki K, Landas SK, Perl A. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest 2009;119:1546-57. [PMID: 19436114 DOI: 10.1172/JCI35722] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
15 Gish RG. Hepatocellular carcinoma: overcoming challenges in disease management. Clin Gastroenterol Hepatol. 2006;4:252-261. [PMID: 16527686 DOI: 10.1016/j.cgh.2006.01.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
16 Perl A, Hanczko R, Telarico T, Oaks Z, Landas S. Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase. Trends Mol Med 2011;17:395-403. [PMID: 21376665 DOI: 10.1016/j.molmed.2011.01.014] [Cited by in Crossref: 102] [Cited by in F6Publishing: 85] [Article Influence: 9.3] [Reference Citation Analysis]
17 Geller DA, Tsung A, Marsh JW, Dvorchik I, Gamblin TC, Carr BI. Outcome of 1000 liver cancer patients evaluated at the UPMC Liver Cancer Center. J Gastrointest Surg. 2006;10:63-68. [PMID: 16368492 DOI: 10.1016/j.gassur.2005.06.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
18 Li X, Zhou X, Guan Y, Wang YX, Scutt D, Gong QY. N-nitrosodiethylamine-induced pig liver hepatocellular carcinoma model: radiological and histopathological studies. Cardiovasc Intervent Radiol 2006;29:420-8. [PMID: 16502159 DOI: 10.1007/s00270-005-0099-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
19 Li J, Wang J, Zhou W, Zhang S, Le Y, He R. Downregulation of BRAF-activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells. Oncol Lett 2017;14:4751-7. [PMID: 29085476 DOI: 10.3892/ol.2017.6770] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
20 Kim KM, Kim SG. Autophagy and microRNA dysregulation in liver diseases. Arch Pharm Res 2014;37:1097-116. [PMID: 25015129 DOI: 10.1007/s12272-014-0439-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
21 Alexander DD, Kelsh MA, Mink PJ, Mandel JH, Basu R, Weingart M. A meta-analysis of occupational trichloroethylene exposure and liver cancer. Int Arch Occup Environ Health. 2007;81:127-143. [PMID: 17492303 DOI: 10.1007/s00420-007-0201-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
22 Skrzycki M, Ścibior D, Podsiad M, Czeczot H. Activity and protein level of CuZnSOD and MnSOD in benign and malignant liver tumors. Clinical Biochemistry 2008;41:91-6. [DOI: 10.1016/j.clinbiochem.2007.09.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]